source
- Tiziana Life Sciences CEO Ivor Elrifi buys 321,423 shares, raising his stake to 4.79 millionTiziana Life Sciences announced that its chief executive, Ivor Elrifi, purchased 321,423 common shares of the company on NASDAQ at $1.00 per share. The transaction brings Elrifi’s total ownership…
- Novo Nordisk reports board and executive share transactions under EU market abuse rulesOn August 6, 2026 Novo Nordisk issued a company announcement detailing share transactions made by members of its board, senior executives and their close associates in line with Article 19 of EU Re…